Gofen & Glossberg’s Sanofi SNY Stock Holding History

Gofen & Glossberg’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-3,600	Closed	-$203K	–	466
2014 Q3	$203K	Buy	+3,600	New	+$193K	0.01%	418
2014 Q2	–	Sell	-3,600	Closed	-$187K	–	492
2014 Q1	$187K	Hold	3,600	–	–	0.01%	421
2013 Q4	$193K	Hold	3,600	–	–	0.01%	414
2013 Q3	$182K	Hold	3,600	–	–	0.01%	399
2013 Q2	$185K	Buy	+3,600	New	+$192K	0.01%	378

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.8B AUM 25.03% 1-Year Est. Return

Gofen & Glossberg's SNY Position: Q4 2014 in Review

Gofen & Glossberg sold out of Sanofi (SNY) in Q4 2014, closing a stake of 3,600 shares — an estimated $203K sold.

Gofen & Glossberg first reported a position in SNY in Q2 2013 and held it in 5 quarters. The position peaked at $203K in Q3 2014. 499 funds tracked by Wall St. Rank hold SNY as of Q4 2014.

Gofen & Glossberg reported no remaining Sanofi position as of Q4 2014 after selling out during the quarter.
Gofen & Glossberg sold 3,600 Sanofi shares in Q4 2014, an estimated $203K.
Gofen & Glossberg first reported a position in Sanofi in Q2 2013 and held it in 5 quarters.
Gofen & Glossberg's Sanofi position peaked at $203K in Q3 2014.
499 funds tracked by Wall St. Rank held Sanofi as of Q4 2014.

Based on Gofen & Glossberg's 13F filing for Q4 2014, filed 9 Feb 2015.